Pediatric Nephrology

, Volume 19, Issue 10, pp 1156–1159 | Cite as

Acacia gum supplementation of a low-protein diet in children with end-stage renal disease

  • Aamir Jalal Al-MosawiEmail author
Brief Report


Patients with end-stage renal disease (ESRD) die in the absence of renal replacement therapy (RRT). In developing countries RRT is not uniformly available and treatment often relies on conservative management and intermittent peritoneal dialysis (IPD). This study investigates the possibility of using acacia gum supplementation to improve the quality of life and provide children with ESRD with a dialysis-free period. Three patients referred to our hospital with ESRD during a 3-month period were enrolled in a therapeutic trial to investigate the efficacy of acacia gum (1 g/kg per day in divided doses) as a complementary conservative measure aimed at improving the quality of life. Inclusion criteria included a pre-dialysis creatinine clearance of <5 ml/min, current dietary restrictions and supplementation, at least one dialysis session to control uremic symptoms, absence of life-threatening complications, and sufficient motivation to ensure compliance with the study protocol. One patient complied with the protocol for only 10 days and died after 6 months, despite IPD. Two patients completed the study. Both reported improved well-being. Neither became acidotic or uremic, and neither required dialysis during the study period. Both patients maintained urinary creatinine and urea levels not previously achieved without dialysis. In conclusion, dietary supplementation with acacia gum may be an alternative to renal replacement therapy to improve the quality of life and reduce or eliminate the need for dialysis in children with ESRD in some developing countries.


Acacia gum Dietary protein End-stage renal disease 



The author is very grateful to the editors of Pediatric Nephrology, with special thanks to Professor Otto Mehls and Ms. Andrea Patters, for their great help in the preparation of this paper. The author is also grateful to Dr. Donna Bliss for her kind, accompanying comments.


  1. 1.
    Lewy PR, Hurley JK (1976) Chronic renal insufficiency. Pediatr Clin North Am 23:829–842PubMedGoogle Scholar
  2. 2.
    Maroni BJ (1998) Protein restriction in the pre-end-stage renal disease (ESRD) patient: who, when, how and the effect on subsequent ESRD outcome. J Am Soc Nephrol 9:S100–S106PubMedGoogle Scholar
  3. 3.
    Ehlayel MS, Akl KF (1992) Childhood chronic renal failure in Qatar. Br J Clin Pract 46:19–20PubMedGoogle Scholar
  4. 4.
    Barratt TM, Greifer I (1999) Pediatric nephrology around the world—overview. In: Barratt TM, Avner ED, Harmon WE (eds) Pediatric nephrology, 4th edn. Lippincott, Williams and Wilkins, Baltimore, pp 1349–1372Google Scholar
  5. 5.
    Bergstrom J, Furst P, Noree LO (1975) Treatment of chronic uremic patients with protein-poor diet and oral supply of essential amino acids. I. Nitrogen balance studies. Clin Nephrol 3:187–194PubMedGoogle Scholar
  6. 6.
    Heidland A, Kult J (1975) Long-term effects of essential amino acids supplementation in patients on regular dialysis treatment. Clin Nephrol 3:234–239PubMedGoogle Scholar
  7. 7.
    Zawad ET Jr (1988) Indications for dialysis. In: Daugirdas JT, Ing TS (eds) Handbook of dialysis. Little Brown, Boston, pp 3–7Google Scholar
  8. 8.
    Barness LA, Johns (1965) Food composition for short method of dietary analysis. In: Wilson ED, Fisher KH, Fuqua ME (eds) Principles of nutrition, 2nd edn. Wiley, New York, pp 528–533Google Scholar
  9. 9.
    Janssen Pharmaceutica (1998) Important safety information on cisapride. Dear Doctor Letter. June 29, 1998Google Scholar
  10. 10.
    Wingen A, Fabian-Bach C, Schaefer F, Mehls O (1997) Randomized multicenter study of low-protein diet on the progression of chronic renal failure in children. European Study Group of Nutritional Treatment of Chronic Renal Failure in Childhood. Lancet 19:1117–1123CrossRefGoogle Scholar
  11. 11.
    Aparicio M, Chauveau P, Combe C (2001) Low protein diets and outcome of renal patients. J Nephrol 14:433–439CrossRefPubMedGoogle Scholar
  12. 12.
    Clark JE, Templeton JY 3rd, McCurdy DK (1962) Perfusion of isolated intestinal loops in the management of chronic renal failure. Trans Am Soc Artif Intern Organs 8:246–251PubMedGoogle Scholar
  13. 13.
    Schloerb PR (1976) Intestinal dialysis in 1975 perspective: sorbents and intestinal loop nitrogen transport. Kidney Int [Suppl] 7:S248–S250Google Scholar
  14. 14.
    Schloerb PR (1990) Intestinal dialysis for kidney failure. Personal experience. ASAIO Trans 36:4–7PubMedGoogle Scholar
  15. 15.
    Dolgin JG, Nix DE, Sanchez J, Watson WA (1991) Pharmacokinetic simulation of the effect of multiple-dose activated charcoal in phenytoin poisoning—report of two pediatric cases. DICP 25:646–649PubMedGoogle Scholar
  16. 16.
    Kucukguclu S, Tuncok Y, Ozkan H, Guven H, Uguz A, Maltepe F (1996) Multiple-dose activated charcoal in an accidental vancomycin overdose. J Toxicol Clin Toxicol 34:83–86PubMedGoogle Scholar
  17. 17.
    Horike K, Usami T, Kamiya Y, Kamiya T, Yoshida A, Itoh S, Yamato H, Ise M, Kimura G (2003) Oral carbonaceous absorbent modifies renal function of renal ablation model without affecting plasma renin-angiotensin system or protein intake. Clin Exp Nephrol 7:120–124CrossRefPubMedGoogle Scholar
  18. 18.
    Yamakado M, Ise M (1999) Mechanism of oral absorbent AST-120 in lipid abnormalities in experimental uremic rats. Kidney Int [Suppl] 71:S190–S192Google Scholar
  19. 19.
    Yatzidis H, Kousticos D, Digenis P (1980) Oral locust bean gum therapy of uremia: favorable effects on biological abnormalities and hypertension. Dial Transplant 9:313–317Google Scholar
  20. 20.
    Bliss DZ, Stein TP, Shleifer CR, Settle RG (1996) Supplementation with gum arabic fiber increases fecal nitrogen excretion and lowers serum urea nitrogen excretion in chronic renal failure patients consuming a low protein diet. Am J Clin Nutr 63:392–398PubMedGoogle Scholar
  21. 21.
    Al-Mosawi AJ (2002) The challenge of chronic renal failure in the developing world: possible use of acacia gum. Pediatr Nephrol 17:390–391CrossRefPubMedGoogle Scholar
  22. 22.
    US Food and Drug Administration (1972) GRAS (generally recommended as safe) food ingredient gum arabic. US Department of Commerce, Washington, D.C. (NT/SnoPB223–614)Google Scholar
  23. 23.
    Phillips GO (1978) Acacia gum (gum arabic), a nutritional fiber: metabolism and caloric value. Food Addit Contam 15:251–264Google Scholar
  24. 24.
    Varcoe R, Halliday D, Carson ER, Richards P, Tavill AS (1975) Efficiency of utilization of urea nitrogen for albumin synthesis by chronically uraemic and normal man. Clin Sci Mol Med 48:379–390PubMedGoogle Scholar
  25. 25.
    Walser M (1974) Urea metabolism in chronic renal failure. J Clin Invest 53:1385–1392PubMedGoogle Scholar
  26. 26.
    Ruman D (1987) Nutrition requirements. In: Braunwald E, Isselbacher KJ, Petersdorf RG, Wilson JD, Martin JD, Fauci AS (eds) Harrison’s principles of internal medicine, 11th edn. McGraw-Hill, pp 383–389Google Scholar
  27. 27.
    Brown CL, Hill MJ, Richards P (1971) Bacterial ureases in uremic men. Lancet I:405–407Google Scholar
  28. 28.
    Vince A, Dawson AM, Park N, O’Grady F (1973) Ammonia production by intestinal bacteria. Gut 14:171–177PubMedGoogle Scholar
  29. 29.
    Tetens I, Livesey G, Eggum BO (1996) Effects of the type and level of dietary fibre supplements on nitrogen retention and excretion patterns. Br J Nutr 75:461–469PubMedGoogle Scholar

Copyright information

© IPNA 2004

Authors and Affiliations

  1. 1.Department of PediatricsUniversity Hospital Al-KadhimiyaBaghdadIraq

Personalised recommendations